Related Experiment Video
Updated: May 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Interactions between the tumor suppressor p53 and immune responses
Daniel Menendez1, Maria Shatz, Michael A Resnick
1Laboratory of Molecular Genetics, Chromosome Stability Section, National Institute of Environmental Health Sciences, National Institutes of Health, North Carolina 27709, USA. menendez@niehs.nih.gov
The tumor suppressor p53 influences innate immunity by regulating Toll-like receptor (TLR) genes. This discovery offers new avenues for cancer diagnosis and therapy, potentially using TLR agonists or antagonists.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- The p53 tumor suppressor is crucial for antitumor defenses, regulating growth arrest, senescence, and apoptosis.
- Emerging research highlights p53's role in diverse biological processes, including immunity.
Purpose of the Study:
- To explore the intricate relationship between p53 and the innate immune system.
- To emphasize the role of the Toll-like receptor (TLR) pathway in p53-mediated immune responses.
- To discuss implications for novel cancer therapies.
Main Methods:
- Review of existing studies on p53, innate immunity, and TLR pathways.
- Analysis of p53's transcriptional network in response to chromosomal stress.
- Examination of p53's regulation of TLR gene expression in human cell lines.
Main Results:
- p53 influences innate immune responses as part of its tumor suppressor functions.
- The complete set of innate immune TLR genes are responsive to chromosomal stress and p53.
- Activation of p53 by antitumor agents modulates TLR gene expression and downstream responses.
Conclusions:
- p53 modulates innate immune gene expression, offering new opportunities for cancer diagnosis.
- Targeting the TLR pathway with agonists or antagonists presents potential chemotherapeutic strategies.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

